| Sign In to gain access to subscriptions and/or personal tools. |
Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosisDepartment of Immunology and Rheumatology, Drum Tower Hospital, Nanjing University Medical School, Nanjing 210008, P. R. China
Department of Immunology and Rheumatology, Drum Tower Hospital, Nanjing University Medical School, Nanjing 210008, P. R. China
Department of Immunology and Rheumatology, Drum Tower Hospital, Nanjing University Medical School, Nanjing 210008, P. R. China
Department of Immunology and Rheumatology, Drum Tower Hospital, Nanjing University Medical School, Nanjing 210008, P. R. China
Institute of Hematology, CAMS & PUMC, Tianjing 300020, P. R. China
Institute of Hematology, CAMS & PUMC, Tianjing 300020, P. R. China
Department of Immunology and Rheumatology, Drum Tower Hospital, Nanjing University Medical School, Nanjing 210008, P. R. China lingyunsun2001{at}yahoo.com.cn Multiple sclerosis (MS) is a chronic autoimmune disorder of the central nervous system. Umbilical cord derived mesenchymal stem cells are immunosuppressive. We transplanted mesenchymal stem cells in a patient with refractory progressive MS, and the disease course was stabilized after the transplantation. We postulate that mesenchymal stem cells have a potent immunosuppressive effect in vivo.
Key Words: multiple sclerosis T2 lesions
Multiple Sclerosis, Vol. 15, No. 5,
644-646 (2009) |
||||